Skip to main content

CORRECTION article

Front. Pharmacol., 28 June 2023
Sec. Ethnopharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1240661

Corrigendum: Curcumin alleviates experimental colitis in mice by suppressing necroptosis of intestinal epithelial cells

This article is a correction to:

  1. Curcumin alleviates experimental colitis in mice by suppressing necroptosis of intestinal epithelial cells

    1. Read original article
Yuting Zhong&#x;Yuting Zhong1†Ye Tu,&#x;Ye Tu2,3†Qingshan MaQingshan Ma4Linlin ChenLinlin Chen3Wenzhao ZhangWenzhao Zhang3Xin LuXin Lu3Shuo Yang Shuo Yang3*Zhibin Wang, Zhibin Wang2,3*Lichao Zhang Lichao Zhang1*
  • 1Department of Pharmacy, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
  • 2Department of Pharmacy, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
  • 3Department of Critical Care Medicine, School of Anesthesiology, Naval Medical University, Shanghai, China
  • 4Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China

A Corrigendum on
Curcumin alleviates experimental colitis in mice by suppressing necroptosis of intestinal epithelial cells

by Zhong Y, Tu Y, Ma Q, Chen L, Zhang W, Lu X, Yang S, Wang Z and Zhang L (2023). Front. Pharmacol. 14:1170637. doi: 10.3389/fphar.2023.1170637

In the published article, there was an error in Affiliations 1 and 2. Instead of “Department of Pharmacy, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, China,” affiliation 1 should be “Department of Pharmacy, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.” Instead of “Department of Pharmacy, Shanghai East Hospital, Tongji University, Shanghai, China,” affiliation 2 should be “Department of Pharmacy, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: curcumin, necroptosis, colitis, intestinal epithelial cells, RIP3

Citation: Zhong Y, Tu Y, Ma Q, Chen L, Zhang W, Lu X, Yang S, Wang Z and Zhang L (2023) Corrigendum: Curcumin alleviates experimental colitis in mice by suppressing necroptosis of intestinal epithelial cells. Front. Pharmacol. 14:1240661. doi: 10.3389/fphar.2023.1240661

Received: 15 June 2023; Accepted: 16 June 2023;
Published: 28 June 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Zhong, Tu, Ma, Chen, Zhang, Lu, Yang, Wang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lichao Zhang, zhanglichao@shutcm.edu.cn; Zhibin Wang, methyl@smmu.edu.cn; Shuo Yang, yangshuo619@163.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.